Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease

• Conditions: Cyanotic Congenital Heart Disease; Pheochromocytoma; Acyanotic Congenital Heart Disease; Paraganglioma

• Registration Number: NCT04891081
• Lead Sponsor: University Medical Centre Ljubljana

Brief Summary

The aim of our study is to compare plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease and possible association with chronic hypoxic stress.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-01
• Status Verified: 2021-05
• Study First Submitted: 2021-05-10
• Study First Submitted QC: 2021-05-13
• Last Update Submitted: 2021-05-13
• Study First Posted: 2021-05-18
• Last Update Posted: 2021-05-18
• Primary Completion: 2021-05-31
• Study Completion: 2021-06-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• patients with congenital heart disease attending regular follow up

Exclusion Criteria

• missing main data in medical documentation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma metanephrine level	baseline, one point of time in a cross-sectional study	Level of plasma metanephrine
Plasma normetanephrine level	baseline, one point of time in a cross-sectional study	Level of plasma normetanephrine

Secondary Outcome Measures

Name	Time	Method
Hypoxemia	baseline, one point of time in a cross-sectional study	Length of hypoxemia presence in years

Trial Locations

Locations (1)

Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; 🇸🇮 Ljubljana, Slovenia